Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy

The strategy utilizing trastuzumab, a humanized monoclonal antibody against human epidermal growth receptor 2 (HER-2), as a therapeutic agent in HER-2 positive breast cancer therapy seems to have advantage over traditional chemotherapy, especially when given in combination with anticancer drugs. How...

Full description

Saved in:
Bibliographic Details
Published in:Polymers (Basel)
Main Authors: Marcinkowska, Monika, Sobierajska, Ewelina, Stanczyk, Maciej, Janaszewska, Anna, Chworos, Arkadiusz, Klajnert-Maculewicz, Barbara
Format: Artigo
Language:Inglês
Published: MDPI 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6414888/
https://ncbi.nlm.nih.gov/pubmed/30966223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/polym10020187
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items